ArticleCardio-oncology (London, England)2025

Real-world analysis of cardiovascular adverse events and risk factors after immune checkpoint inhibitor therapy.

Yanfei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.